Ana Cerdeira, Ph.D.

Ana Cerdeira, Ph.D., VP, Global Head Commercial, Development Assets, Innovative Medicines Group, Grunenthal Group- Ana brings almost two decades of experience in global business development and strategic portfolio management. Prior to joining Grünenthal, Ana held several leadership positions at Molecular Partners as VP Strategic Planning and Portfolio Management and at Takeda Pharmaceuticals, as VP of Emerging Markets Portfolio Management. Previously, Ana held several positions at Janssen Pharmaceuticals, including CMC Drug Product Leader. She earned a MPharm from the University of Lisbon, Portugal and a Ph.D. from Eidgenössische Technische Hochschule Zürich (ETH Zürich), Switzerland.